A Study of GLB-001 in Patients With Myeloid Malignancies
A Study of GLB-001 in Patients With Myeloid Malignancies
Recruiting · NCT06378437 · Registry updated 2025-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of GLB-001 in Patients With Myeloid Malignancies | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplasms by Site, acquired polycythemia vera, acute myeloid leukemia, blood coagulation disease, blood platelet disease, bone marrow disorder, bone marrow neoplasm, essential thrombocythemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, leukemia, myelodysplastic syndrome, myeloid leukemia, myeloid neoplasm, neoplasm, primary myelofibrosis, thrombocytosis disease | Recruiting | Phase 1 | 2025-08-19 | NCT06378437 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hangzhou GluBio Pharmaceutical Co., Ltd. | 2 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.